Showing 5741-5750 of 20432 results for "".
- The Evolutionary Mechanics of Placenta Shape Modern Obstetricshttps://reachmd.com/news/the-evolutionary-mechanics-of-placenta-shape-modern-obstetrics/2475546/Evolutionary mechanisms within the placenta, such as the invasion of maternal spiral arteries by extravillous trophoblasts, continue to dictate modern gestations, shaping maternal-fetal dynamics and clinical outcomes in ways obstetricians are
- Balancing PSMA Radioligand Therapy in Metastatic Prostate Cancer with Comorbid Leukopeniahttps://reachmd.com/news/balancing-psma-radioligand-therapy-in-metastatic-prostate-cancer-with-comorbid-leukopenia/2475550/Emerging PSMA radioligand therapy regimens are advancing care for metastatic prostate cancer, yet clinicians must navigate the narrow margin between potent tumor control and hematologic safety. Managing metastatic prostate cancer incre
- EMP1’s Role in Pancreatic Tumor Progression and Precision Oncologyhttps://reachmd.com/news/emp1s-role-in-pancreatic-tumor-progression-and-precision-oncology/2475547/EMP1’s unexpected influence on pancreatic tumor progression is forcing a rethink of current therapies and opening doors to precision oncology approaches. In the context of pancreatic cancer, where the
- Evolving Nutritional Strategies in Managing Gynecological Diseaseshttps://reachmd.com/news/evolving-nutritional-strategies-in-managing-gynecological-diseases/2475549/Emerging evidence has uncovered how targeted dietary modifications can reshape inflammatory and hormonal pathways in conditions like endometriosis and polycystic ovarian syndrome, opening a new frontier in women's health management. Cl
- Navigating Therapeutic Decisions in Hepatocellular Carcinoma: TACE vs. TAREhttps://reachmd.com/news/navigating-therapeutic-decisions-in-hepatocellular-carcinoma-tace-vs-tare/2475553/Therapeutic decisions in early and intermediate-stage hepatocellular carcinoma demand careful weighing of locoregional modalities whose survival outcomes can diverge significantly. For oncologists, choosing between transarterial chemoe
- Transforming Dry Eye Treatment Through Patient Education and Storytellinghttps://reachmd.com/news/transforming-dry-eye-treatment-through-patient-education-and-storytelling/2475521/Dry eye disease remains an often underdiagnosed yet impactful condition, affecting approximately 16 million Americans. Understanding the intersection of patient education and effective m
- Navigating the Rise of At-Home Red Light Therapy in Dermatologyhttps://reachmd.com/news/navigating-the-rise-of-at-home-red-light-therapy-in-dermatology/2475524/Recent data indicates a significant increase in consumer interest for at-home Red Light Therapy devices, with social media playing a substantial role in shaping patient expectations and purchasing behaviors. According to a
- Advancing Dermatologic Surgery: Precision Lasers and Nerve Visualizationhttps://reachmd.com/news/advancing-dermatologic-surgery-precision-lasers-and-nerve-visualization/2475531/Laser irradiation technology is advancing dermatology and cosmetic surgery, particularly in treating skin discolorations. Surgeons must navigate the complexity of pulse duration and fluence, which is the energy per unit area, to minimize ther
- Understanding Pollen Surges: New Clinical Challenges in Europehttps://reachmd.com/news/understanding-pollen-surges-new-clinical-challenges-in-europe/2475538/Recent data reveal that pollen spikes in Europe have led to hay fever–like symptoms in individuals with no prior allergy histor
- Harnessing Antibody-Drug Conjugates for Aggressive Lymphoma Treatmenthttps://reachmd.com/news/harnessing-antibody-drug-conjugates-for-aggressive-lymphoma-treatment/2475503/In the evolving landscape of lymphoma treatment, antibody-drug conjugates are being investigated for their potential to target aggressive forms of the disease. Effectively treating aggressive lymphomas has long been ha